Caius Radu

Radu Laboratory at UCLA is seeking a Postdoctoral Scholar in Nuclear Medicine and Theranostics. The project is centered on developing novel RNA-lipid nanoparticle (RNA-LNP) cancer immunotherapy platforms and studying how these approaches shape innate and adaptive antitumor immunity. The successful candidate will join the laboratory of Professor Caius Radu in the Department of Nuclear Medicine and Theranostics and the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles. The work combines mechanistic immunology with translational cancer research, with a strong emphasis on dendritic cell biology, antigen-specific CD8 + T-cell responses, and comparative studies in human and murine immune systems. The role involves designing and running mechanistic and translational studies, characterizing immune responses, and testing therapeutic activity in preclinical tumor models. The postdoctoral scholar will also analyze experimental data, contribute to manuscripts, and participate in collaborative projects across a multidisciplinary research environment. The Radu laboratory is affiliated with the Parker Institute for Cancer Immunotherapy and the UCLA Health Jonsson Comprehensive Cancer Center. Professor Radu also leads the Cancer Molecular Imaging, Nanotechnology, and Theranostics Research Program, creating an environment that connects fundamental cancer biology, immunology, and translational therapeutics. The lab emphasizes scientific creativity, intellectual rigor, collaboration, and mentorship aimed at developing scientific independence and leadership. Overall, this is a research-intensive postdoctoral opportunity at UCLA focused on RNA-based cancer immunotherapy, immune mechanism discovery, and preclinical translation.